ecoli-uk.com

E.coli O157 & Haemolytic Uraemic Syndrome


HUSH supports application for feasibility study of the drug Eculizumab

5th October 2014

HUSH has supported an application for a feasibility study of the drug Eculizumab, for HUS sufferers.

The drug is currently being successfully used for sufferers of a similar illness called aHUS.

This application is supported by medical and public health experts who believe that this drug could be helpful for sufferers of HUS.

The funding application for this study to the National Institute of Health Research is at a very early stage of the process.

The application is lead by Dr Sally Johnson a Consultant Paediatric Nephrologist at Great North Children's Hospital Newcastle and is supported by Paediatric Nephrologists in England, Wales & Scotland.

If the feasibility application & study is successful it is hoped that a trial of the drug will be carried out on HUS sufferers.




Page
1 of 50
Next > Last >>

27th May 2025

There were 2063 cultured confirm... ...read on
24th April 2025

16th April 2025    Case Reference: IC-348... ...read on
5th March 2025

The Information Commissioner's office (ICO) Freedom of Information decision notice of 05/03/2025 stated    ... ...read on
14th February 2025

At any price point, the food you purchase should be safe whatever your dietary requirements are. However foodborne illness is estimated to cost 10.4 billion pounds annually in the UK by government. ... ...read on
22nd December 2024

UK Health Security Agency  By email  ste... ...read on
Page
1 of 50
Next > Last >>

Designed by Robert Woods. View our Cookie & Privacy Policy